Skip to content
Products & Services · Net revenues

Other Aesthetics — Net revenues

AbbVie Other Aesthetics — Net revenues decreased by 10.6% to $286M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.2%, from $315M to $286M. Over 4 years (FY 2021 to FY 2025), Other Aesthetics — Net revenues shows a downward trend with a -3.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 8, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful market penetration or expansion of the secondary aesthetic product portfolio, while a decrease may suggest market saturation or shifting consumer preferences away from these specific treatments.

Detailed definition

This metric represents the total net sales generated from the company's secondary portfolio of aesthetic products, exclu...

Peer comparison

Peers in the medical aesthetics and dermatology space typically report this as a sub-segment of their broader aesthetics or consumer health divisions, often categorized as 'other' or 'emerging' product lines.

Metric ID: abbv_segment_other_aesthetics_net_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$422M$352M$349M$323M$332M$312M$323M$286M$331M$298M$319M$319M$318M$310M$332M$315M$327M$303M$320M$286M
QoQ Change-16.6%-0.9%-7.4%+2.8%-6.0%+3.5%-11.5%+15.7%-10.0%+7.0%+0.0%-0.3%-2.5%+7.1%-5.1%+3.8%-7.3%+5.6%-10.6%
YoY Change-21.3%-11.4%-7.4%-11.5%-0.3%-4.5%-1.2%+11.5%-3.9%+4.0%+4.1%-1.3%+2.8%-2.3%-3.6%-9.2%
Range$286M$422M
CAGR-7.9%
Avg YoY Growth-3.5%
Median YoY Growth-2.9%

Frequently Asked Questions

What is AbbVie's other aesthetics — net revenues?
AbbVie (ABBV) reported other aesthetics — net revenues of $286M in Q1 2026.
How has AbbVie's other aesthetics — net revenues changed year-over-year?
AbbVie's other aesthetics — net revenues decreased by 9.2% year-over-year, from $315M to $286M.
What is the long-term trend for AbbVie's other aesthetics — net revenues?
Over 4 years (2021 to 2025), AbbVie's other aesthetics — net revenues has grown at a -3.6% compound annual growth rate (CAGR), from $1.47B to $1.27B.
What does other aesthetics — net revenues mean?
Total revenue generated from secondary aesthetic product lines.